chrX-120426362-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_002294.3(LAMP2):c.*4961A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00040 ( 0 hom., 10 hem., cov: 20)
Consequence
LAMP2
NM_002294.3 3_prime_UTR
NM_002294.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.911
Publications
1 publications found
Genes affected
LAMP2 (HGNC:6501): (lysosomal associated membrane protein 2) The protein encoded by this gene is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. It may play a role in tumor cell metastasis. It may also function in the protection, maintenance, and adhesion of the lysosome. Alternative splicing of this gene results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2008]
LAMP2 Gene-Disease associations (from GenCC):
- Danon diseaseInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.73).
BP6
Variant X-120426362-T-C is Benign according to our data. Variant chrX-120426362-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 367739.
BS2
High Hemizygotes in GnomAd4 at 10 XL gene
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_002294.3. You can select a different transcript below to see updated ACMG assignments.
Frequencies
GnomAD3 genomes AF: 0.000405 AC: 44AN: 108597Hom.: 0 Cov.: 20 show subpopulations
GnomAD3 genomes
AF:
AC:
44
AN:
108597
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.000405 AC: 44AN: 108650Hom.: 0 Cov.: 20 AF XY: 0.000323 AC XY: 10AN XY: 30930 show subpopulations
GnomAD4 genome
AF:
AC:
44
AN:
108650
Hom.:
Cov.:
20
AF XY:
AC XY:
10
AN XY:
30930
show subpopulations
African (AFR)
AF:
AC:
1
AN:
29845
American (AMR)
AF:
AC:
2
AN:
9962
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2600
East Asian (EAS)
AF:
AC:
0
AN:
3494
South Asian (SAS)
AF:
AC:
0
AN:
2460
European-Finnish (FIN)
AF:
AC:
0
AN:
5590
Middle Eastern (MID)
AF:
AC:
0
AN:
216
European-Non Finnish (NFE)
AF:
AC:
40
AN:
52346
Other (OTH)
AF:
AC:
1
AN:
1458
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
ClinVar submissions
View on ClinVar Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
Pathogenic
VUS
Benign
Condition
-
2
-
Danon disease (2)
-
1
-
Hypertrophic cardiomyopathy (1)
-
-
1
not provided (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.